Cathy graduated from Indiana University Southeast with a bachelor's degree in English. Over her nine-year content writing career, Cathy has developed a knack for untangling complex information and ...
Thanks to AI, data science tasks that once demanded specialized skills can now be performed faster, more accurately and at a ...
The company also collaborates with pharmaceutical companies to bring new molecules to market using its technologies, like PharmFilm. Aquestive is advancing a late-stage proprietary product candidate ...
The FDA lifted the partial clinical hold on Arcellx Inc's ACLX iMMagine-1 Phase 2 Clinical Program. The move follows alignment with FDA on modifications to the iMMagine-1 trial protocol related to ...
UniQure said the U.S. Food and Drug Administration no longer agreed that clinical data for the Dutch company's gene therapy ...
The CEO highlighted results from the REMAIN-1 Midpoint Cohort, where "Revita-treated patients lost an additional 2.5% of total body weight, while patients in the sham group regained about 10%, a ...
Q3 2025 Management View CEO Peter Altman provided updates on regulatory progress for CardiAMP cell therapy targeting ischemic heart failure, noting, "we have been working on regulatory submissions on ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback